Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Regular physical activity and mammographic density: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Residential traffic noise and mammographic breast density in the Diet, Cancer, and Health cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence, type distribution, and risk factors for oral HPV in Danish renal transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Albina N Minlikeeva
  • Jo L Freudenheim
  • Rikki A Cannioto
  • J Brian Szender
  • Kevin H Eng
  • Francesmary Modugno
  • Roberta B Ness
  • Michael J LaMonte
  • Grace Friel
  • Brahm H Segal
  • Kunle Odunsi
  • Paul Mayor
  • Emese Z Zsiros
  • Barbara Schmalfeldt
  • Rüdiger Klapdor
  • Thilo Dӧrk
  • Peter Hillemanns
  • Linda E Kelemen
  • Martin Kӧbel
  • Helen Steed
  • Anna de Fazio
  • Susan J Jordan
  • Christina M Nagle
  • Harvey A Risch
  • Mary Anne Rossing
  • Jennifer A Doherty
  • Marc T Goodman
  • Robert Edwards
  • Keitaro Matsuo
  • Mika Mizuno
  • Beth Y Karlan
  • Susanne K Kjær
  • Estrid Høgdall
  • Allan Jensen
  • Joellen M Schildkraut
  • Kathryn L Terry
  • Daniel W Cramer
  • Elisa V Bandera
  • Lisa E Paddock
  • Lambertus A Kiemeney
  • Leon F Massuger
  • Jolanta Kupryjanczyk
  • Andrew Berchuck
  • Jenny Chang-Claude
  • Brenda Diergaarde
  • Penelope M Webb
  • Kirsten B Moysich
  • Australian Ovarian Cancer Study Group
Vis graf over relationer

PURPOSE: Survival following ovarian cancer diagnosis is generally low; understanding factors related to prognosis could be important to optimize treatment. The role of previously diagnosed comorbidities and use of medications for those conditions in relation to prognosis for ovarian cancer patients has not been studied extensively, particularly according to histological subtype.

METHODS: Using pooled data from fifteen studies participating in the Ovarian Cancer Association Consortium, we examined the associations between history of hypertension, heart disease, diabetes, and medications taken for these conditions and overall survival (OS) and progression-free survival (PFS) among patients diagnosed with invasive epithelial ovarian carcinoma. We used Cox proportional hazards regression models adjusted for age and stage to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) overall and within strata of histological subtypes.

RESULTS: History of diabetes was associated with increased risk of mortality (n = 7,674; HR = 1.12; 95% CI = 1.01-1.25). No significant mortality associations were observed for hypertension (n = 6,482; HR = 0.95; 95% CI = 0.88-1.02) or heart disease (n = 4,252; HR = 1.05; 95% CI = 0.87-1.27). No association of these comorbidities was found with PFS in the overall study population. However, among patients with endometrioid tumors, hypertension was associated with lower risk of progression (n = 339, HR = 0.54; 95% CI = 0.35-0.84). Comorbidity was not associated with OS or PFS for any of the other histological subtypes. Ever use of beta blockers, oral antidiabetic medications, and insulin was associated with increased mortality, HR = 1.20; 95% CI = 1.03-1.40, HR = 1.28; 95% CI = 1.05-1.55, and HR = 1.63; 95% CI = 1.20-2.20, respectively. Ever use of diuretics was inversely associated with mortality, HR = 0.71; 95% CI = 0.53-0.94.

CONCLUSIONS: Histories of hypertension, diabetes, and use of diuretics, beta blockers, insulin, and oral antidiabetic medications may influence the survival of ovarian cancer patients. Understanding mechanisms for these observations could provide insight regarding treatment.

OriginalsprogEngelsk
TidsskriftCancer causes & control : CCC
Vol/bind28
Udgave nummer5
Sider (fra-til)469-486
ISSN0957-5243
DOI
StatusUdgivet - maj 2017

ID: 50607795